Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
J Perinat Neonatal Nurs ; 31(4): 350-357, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29068853

RESUMEN

Rhizomelic chondrodysplasia punctata (RCDP) is a rare genetic peroxisome biogenesis disorder with a reported incidence of 1 in 100 000 live births. The 3 genetic subtypes of RCDP are acquired by an autosomal recessive inheritance pattern. RCDP type 1 accounts for greater than 90% of all aggregate cases. Differentiating between the 3 subtypes of RCDP, as well as disorders characterized by similar punctate cartilaginous changes, is essential to guide an appropriate postnatal plan of care. Management strategies are focused toward associated clinical manifestations and require an interdisciplinary approach including ophthalmology, cardiovascular, endocrine, physical and occupational therapy, and neurology. Purposeful and frequent collaboration among all members of the neonatal/pediatric interdisciplinary team is necessary to optimize outcomes for the neonate and the family unit. The purpose of this article is to anticipate the needs of both patients with known and prenatal diagnosis of RCDP type 1 and patients with suspected clinical diagnosis of RCDP type 1 in the immediate neonatal period and to guide the appropriate plan of care. This article presents a case report of type I RCDP, as well as describes genetic influences, symptoms, diagnosis, management, and prognosis.


Asunto(s)
Condrodisplasia Punctata Rizomélica/genética , Condrodisplasia Punctata Rizomélica/terapia , Predisposición Genética a la Enfermedad , Adulto , Puntaje de Apgar , Cesárea , Condrodisplasia Punctata Rizomélica/diagnóstico por imagen , Terapia Combinada , Femenino , Humanos , Recién Nacido , Masculino , Receptor de la Señal 2 de Direccionamiento al Peroxisoma/deficiencia , Embarazo , Diagnóstico Prenatal , Pronóstico
2.
Pediatr Res ; 64(3): 270-4, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18458654

RESUMEN

Although apnea is common in premature babies, there is a paucity of information concerning the pathophysiologic basis of these episodes and their relationship to other perinatal conditions such as hyperbilirubinemia. Unconjugated hyperbilirubinemia in premature infants, even in moderately high levels, may cause encephalopathy affecting brainstem functions and has been linked to increased incidence of apnea in these infants. Thus, there is a need to clarify mechanisms by which bilirubin may alter respiratory control and induce apnea of prematurity. In this study, bilirubin or placebo was infused i.v. in 9-d-old rat pups (n = 36). Serum hyperbilirubinemia peaked in the first hours after bilirubin infusion. Twenty-four hours after bilirubin infusion, respiration was recorded by plethysmography at rest and under hypercapnic and hypoxic conditions. In treated pups, minute ventilation in room air was significantly reduced, hyperventilatory response to CO2 was blunted, and hypoxic ventilatory depression was increased, compared with placebo-injected rat pups. Brainstem bilirubin deposition and immunoreactivity to bilirubin was detected in the brainstem on histologic analysis. We speculate that high serum bilirubin levels may cause prolonged inhibition of brainstem autonomic function and that this could underlie the exacerbation of apnea noted in premature babies who have experienced jaundice.


Asunto(s)
Bilirrubina/efectos adversos , Tronco Encefálico/fisiopatología , Hiperbilirrubinemia/inducido químicamente , Hiperbilirrubinemia/fisiopatología , Fenómenos Fisiológicos Respiratorios , Animales , Animales Recién Nacidos , Apnea/fisiopatología , Bilirrubina/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Hipercapnia/fisiopatología , Hipoxia/fisiopatología , Bulbo Raquídeo/metabolismo , Ventilación Pulmonar/fisiología , Ratas , Ratas Sprague-Dawley , Albúmina Sérica/metabolismo
3.
Pediatr Res ; 60(2): 136-40, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16864692

RESUMEN

We used a rat pup model to delineate whether mechanical ventilation of 95% O2). After each intervention, they were returned to their mothers. On d 10 of life, all animals were anesthetized, paralyzed, and ventilated to measure pulmonary function. Total lung resistance (RL) and dynamic lung compliance (Cdyn) were measured in response to increasing intravenous doses of methacholine (0.03-1 microg/g) by head-out body plethysmography. Injection of methacholine caused a dose-dependent increase in RL and decrease in Cdyn. The response of both RL and Cdyn to methacholine was significantly potentiated by prior exposure to mechanical ventilation when compared with unventilated normoxic controls. The addition of hyperoxia to mechanical ventilation did not further potentiate responses to methacholine. Mechanical ventilation did not alter lung myosin or the number of inflammatory cells in airways of room air ventilated versus unventilated control animals. We conclude that a brief period of mechanical ventilation in rat pups increases airway reactivity 48 h after such exposure in the presence as well as absence of hyperoxic exposure. This represents a potentially important model to investigate the mechanisms involved in airway hyperreactivity induced by neonatal lung injury.


Asunto(s)
Resistencia de las Vías Respiratorias , Pulmón/fisiología , Respiración Artificial/métodos , Resistencia de las Vías Respiratorias/efectos de los fármacos , Animales , Animales Recién Nacidos , Broncoconstrictores/administración & dosificación , Femenino , Intubación Intratraqueal , Pulmón/química , Pulmón/citología , Rendimiento Pulmonar , Cloruro de Metacolina/administración & dosificación , Miosinas/análisis , Embarazo , Ratas
4.
Early Hum Dev ; 81(2): 171-9, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15748972

RESUMEN

The in-hospital management of infants with BPD includes minimizing the duration of mechanical ventilation and avoiding the use of high inspired oxygen concentrations while maintaining adequate oxygenation. Fluid restriction, bronchodilators, and diuretic therapy can improve lung function and reduce the need for supplemental oxygen and high ventilator settings, but do not change the ultimate course of these infants. Corticosteroids also improve lung function and accelerate weaning from oxygen and mechanical ventilation, but their use during the first weeks of life is associated with worse neurological outcome. Adequate nutrition plays an important role in lung injury protection and recovery. Infants with severe BPD frequently develop pulmonary hypertension and may benefit from the use of pulmonary vasodilators. Outpatient management must be carefully planned and carried out by experienced multidisciplinary teams. Social and financial issues must be addressed with the family and caregivers. Home oxygen and mechanical ventilation therapy are used frequently after discharge and require specialized staff and equipment. Maintenance of oxygenation and proper nutritional support are critical aspects in the post-discharge management of these infants. Immunizations and RSV prevention are also important to prevent infections in these vulnerable immunocompromised patients.


Asunto(s)
Displasia Broncopulmonar/terapia , Terapia por Inhalación de Oxígeno/métodos , Corticoesteroides/uso terapéutico , Atención Ambulatoria/métodos , Broncodilatadores/uso terapéutico , Diuréticos/uso terapéutico , Humanos , Recién Nacido , Recien Nacido Prematuro , América del Norte , Fenómenos Fisiológicos de la Nutrición , Respiración Artificial/métodos , Vasodilatadores/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA